Showing results (221-230 of 504) with videos related to
Sort By:
Pageof 51
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.Physiological Reports|April 17, 2026
Are saliva and bile sources of oxalate secretion into the human gastrointestinal tract?Emma Earhart, Thomas Tielleman, John Knight, et al.Journal of Addiction Medicine|June 18, 2015
Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis UsersTauheed Zaman, Monica Malowney, John Knight, et al.Circulation|October 12, 2011
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific regionRachel R Huxley, Federica Barzi, Tai Hing Lam, et al.Diabetes, Obesity & Metabolism|September 6, 2023
The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trialJie Yu, Arianne N Sweeting, Chris Gianacas, et al.Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.The New England Journal of Medicine|October 25, 2024
Alternative Complement Pathway Inhibition with Iptacopan in IgA NephropathyVlado Perkovic, Jonathan Barratt, Brad Rovin, et al.Annals of Internal Medicine|March 21, 2012
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysisSuetonia C Palmer, Lucia Di Micco, Mona Razavian, et al.Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.Pageof 51